Pharma & Healthcare
Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled…
- Types
- IBS-D Drug · IBS-C Drug · Others
- Applications
- Women · Men
5 editions26 December 2025
$2,950Single user · USD · Industry ResearchExplore product: Irritable Bowel Syndrome (IBS)Compare research options for Irritable Bowel Syndrome (IBS)